Axitinib News and Research

RSS
Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Age-related changes in the blood system can exacerbate colon cancer

Age-related changes in the blood system can exacerbate colon cancer

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Drug combinations could become first-line treatment for metastatic kidney cancer

Drug combinations could become first-line treatment for metastatic kidney cancer

Physicians more likely to prescribe drugs of manufacturers who paid them money

Physicians more likely to prescribe drugs of manufacturers who paid them money

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Recycling existing drugs may help fight several types of cancer

Recycling existing drugs may help fight several types of cancer

Potential therapeutic approaches to combat chronic myeloid leukemia

Potential therapeutic approaches to combat chronic myeloid leukemia

New clinical trial uses aggressive treatment method for patients with pancreas cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Rabbit virus can be paired with existing drug to deliver more potent punch to brain tumor cells

Rabbit virus can be paired with existing drug to deliver more potent punch to brain tumor cells

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

First-line axitinib ‘feasible’ in advanced, metastatic RCC

First-line axitinib ‘feasible’ in advanced, metastatic RCC

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Long-term axitinib in RCC effective with ‘controllable’ toxicities

Long-term axitinib in RCC effective with ‘controllable’ toxicities

RCC renal function independent of axitinib-induced proteinuria

RCC renal function independent of axitinib-induced proteinuria

Nonlinear correlation between axitinib dose, dBP increase

Nonlinear correlation between axitinib dose, dBP increase

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.